| pubmed-article:17804150 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17804150 | lifeskim:mentions | umls-concept:C0042029 | lld:lifeskim |
| pubmed-article:17804150 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17804150 | lifeskim:mentions | umls-concept:C1533685 | lld:lifeskim |
| pubmed-article:17804150 | lifeskim:mentions | umls-concept:C1180419 | lld:lifeskim |
| pubmed-article:17804150 | lifeskim:mentions | umls-concept:C0006050 | lld:lifeskim |
| pubmed-article:17804150 | lifeskim:mentions | umls-concept:C1536696 | lld:lifeskim |
| pubmed-article:17804150 | lifeskim:mentions | umls-concept:C0231220 | lld:lifeskim |
| pubmed-article:17804150 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
| pubmed-article:17804150 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
| pubmed-article:17804150 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:17804150 | pubmed:dateCreated | 2008-2-5 | lld:pubmed |
| pubmed-article:17804150 | pubmed:abstractText | To study the effect of botulinum toxin A (BoNTA) injections into the detrusor muscle on the incidence of symptomatic urinary infections in patients with neurogenic detrusor overactivity. | lld:pubmed |
| pubmed-article:17804150 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17804150 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17804150 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17804150 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17804150 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17804150 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17804150 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17804150 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:17804150 | pubmed:issn | 0302-2838 | lld:pubmed |
| pubmed-article:17804150 | pubmed:author | pubmed-author:GaméXavierX | lld:pubmed |
| pubmed-article:17804150 | pubmed:author | pubmed-author:RischmannPasc... | lld:pubmed |
| pubmed-article:17804150 | pubmed:author | pubmed-author:MarquePhilipp... | lld:pubmed |
| pubmed-article:17804150 | pubmed:author | pubmed-author:MalavaudBerna... | lld:pubmed |
| pubmed-article:17804150 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:17804150 | pubmed:author | pubmed-author:Castel-Lacana... | lld:pubmed |
| pubmed-article:17804150 | pubmed:author | pubmed-author:BentalebYouss... | lld:pubmed |
| pubmed-article:17804150 | pubmed:author | pubmed-author:Thiry-Escudié... | lld:pubmed |
| pubmed-article:17804150 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17804150 | pubmed:volume | 53 | lld:pubmed |
| pubmed-article:17804150 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17804150 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17804150 | pubmed:pagination | 613-8 | lld:pubmed |
| pubmed-article:17804150 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:meshHeading | pubmed-meshheading:17804150... | lld:pubmed |
| pubmed-article:17804150 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:17804150 | pubmed:articleTitle | Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. | lld:pubmed |
| pubmed-article:17804150 | pubmed:affiliation | Service d'Urologie, Transplantation Rénale et Andrologie, CHU Rangueil, Toulouse, France. xaviergame@hotmail.com | lld:pubmed |
| pubmed-article:17804150 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17804150 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:17804150 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17804150 | lld:pubmed |
